SEC Form 4 · accession 0001437749-15-022568
VIVEVE MEDICAL, INC. · VIVE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patricia Scheller
Officer — Chief Executive Officer · Director
Period of report
Dec 16, 2015
Accepted (ET)
Dec 18, 2015 · 9:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879682
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (Right to Purchase)F1 | $0.75 | Dec 16, 2015 | A | 1,936,001 | A | — | Dec 16, 2025 | Common Stock | 1,936,001 | 3,097,180 | D |
| Warrant to Purchase Common StockF2 | $0.50 | holding | — | — | — | Feb 17, 2015 | Feb 17, 2025 | Common Stock | 205,824 | 205,814 | D |
Explanation of responses
- F1The reporting person is a participant in the Issuer's 2013 Stock Option and Incentive Plan, as amended, and received 1,936,001 incentive stock options on December 16, 2015. The incentive stock options vest over a period of four years beginning on the grant date in increments of 1/48th per month.
- F2The grant of this warrant was reported on February 18, 2015.